Microbial drug resistance (Larchmont, N.Y.) · 2026
Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli from Community Fecal Samples in Sivas, Türkiye: Detection of the ST131 Clone.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Arslan Murat, Öztop A Yasemin
Аннотация
BACKGROUNDS: This study aimed to determine beta-lactamase genes, clonal relationships, and the prevalence of the E.coli sequence type 131 (ST131) clone in extended-spectrum beta-lactamase (ESBL)-producing E.coli (ESBL-Ec) strains isolated from community fecal samples.
METHODS: A total of 161 fecal samples were collected from healthy individuals and outpatients at Sivas Cumhuriyet University Hospital. ESBL-Ec isolates obtained from these samples were analyzed. Antimicrobial susceptibility was determined by the disc diffusion method following EUCAST guidelines. The presence of blaTEM, blaSHV, blaCTX-M, blaOXA, blaPER, blaVEB, and blaGES genes was investigated by multiplex PCR. The ST131 clone was detected by PCR and Multi Locus Sequence Typing analyses. Clonal relatedness among ESBL-Ec strains was evaluated using ERIC-PCR.
RESULTS: The fecal ESBL-Ec carriage rate was 31.05%. Resistance rates to ciprofloxacin, trimethoprim-sulfamethoxazole, gentamicin, amikacin, and ertapenem were 38%, 58%, 14%, 6%, and 4%, respectively. ESBL genes were detected at rates of blaTEM 82%, blaCTX-M 68%, and blaOXA 10%. ESBL-Ec isolates were grouped into 15 clusters, and 5 (10%) of 50 isolates were identified as the ST131 clone.
CONCLUSION: This first study in Sivas, Türkiye, shows a high fecal carriage rate of ESBL-Ec and the presence of the E.coli ST131 clone.
METHODS: A total of 161 fecal samples were collected from healthy individuals and outpatients at Sivas Cumhuriyet University Hospital. ESBL-Ec isolates obtained from these samples were analyzed. Antimicrobial susceptibility was determined by the disc diffusion method following EUCAST guidelines. The presence of blaTEM, blaSHV, blaCTX-M, blaOXA, blaPER, blaVEB, and blaGES genes was investigated by multiplex PCR. The ST131 clone was detected by PCR and Multi Locus Sequence Typing analyses. Clonal relatedness among ESBL-Ec strains was evaluated using ERIC-PCR.
RESULTS: The fecal ESBL-Ec carriage rate was 31.05%. Resistance rates to ciprofloxacin, trimethoprim-sulfamethoxazole, gentamicin, amikacin, and ertapenem were 38%, 58%, 14%, 6%, and 4%, respectively. ESBL genes were detected at rates of blaTEM 82%, blaCTX-M 68%, and blaOXA 10%. ESBL-Ec isolates were grouped into 15 clusters, and 5 (10%) of 50 isolates were identified as the ST131 clone.
CONCLUSION: This first study in Sivas, Türkiye, shows a high fecal carriage rate of ESBL-Ec and the presence of the E.coli ST131 clone.